| 1 | rated | 3,724 |
| 2 | scored | 2,442 |
| 3 | ranked | 581 |
| 4 | valued | 369 |
| 5 | canvassed | 5 |
| 6 | regraded | 4 |
| 7 | archery | 2 |
| 8 | dark-triggered | 2 |
| 9 | hoch | 2 |
| 10 | included.vasopressin | 2 |
| 11 | sanitised | 2 |
| 12 | ytw | 2 |
| 13 | 'affecting | 1 |
| 14 | 1.25/100 | 1 |
| 15 | 15,664 | 1 |
| 16 | 2.04/100 | 1 |
| 17 | 4.5/100 | 1 |
| 18 | 5.88/100 | 1 |
| 19 | aggrandized | 1 |
| 20 | anorexia/decreased | 1 |
| 21 | as/than | 1 |
| 22 | assesse | 1 |
| 23 | assessed. | 1 |
| 24 | began/wrote/astonished | 1 |
| 25 | diabetes-is | 1 |
| 26 | dissemination/cochrane | 1 |
| 27 | estimated.for | 1 |
| 28 | estrogens-specifically | 1 |
| 29 | excluded.for | 1 |
| 30 | fat-positive/inflammation-positive | 1 |
| 31 | future-proof | 1 |
| 32 | gal-3-were | 1 |
| 33 | harass | 1 |
| 34 | impregnates | 1 |
| 35 | interaction-and | 1 |
| 36 | male.the | 1 |
| 37 | neurotoxicities-were | 1 |
| 38 | noticed.the | 1 |
| 39 | prechewed | 1 |
| 40 | precommercial | 1 |
| 41 | preinformed | 1 |
| 42 | purpose-trained | 1 |
| 43 | quality-graded | 1 |
| 44 | re-consulted | 1 |
| 45 | re-cultivate | 1 |
| 46 | retune | 1 |
| 47 | self-assessing | 1 |
| 48 | strokesand | 1 |
| 49 | trait-positive | 1 |
| 50 | waiting.for | 1 |
| 1 | 'affecting | 1 |
| 2 | 1.25/100 | 1 |
| 3 | 15,664 | 1 |
| 4 | 2.04/100 | 1 |
| 5 | 4.5/100 | 1 |
| 6 | 5.88/100 | 1 |
| 7 | aggrandized | 1 |
| 8 | anorexia/decreased | 1 |
| 9 | archery | 2 |
| 10 | as/than | 1 |
| 11 | assesse | 1 |
| 12 | assessed. | 1 |
| 13 | began/wrote/astonished | 1 |
| 14 | canvassed | 5 |
| 15 | dark-triggered | 2 |
| 16 | diabetes-is | 1 |
| 17 | dissemination/cochrane | 1 |
| 18 | estimated.for | 1 |
| 19 | estrogens-specifically | 1 |
| 20 | excluded.for | 1 |
| 21 | fat-positive/inflammation-positive | 1 |
| 22 | future-proof | 1 |
| 23 | gal-3-were | 1 |
| 24 | harass | 1 |
| 25 | hoch | 2 |
| 26 | impregnates | 1 |
| 27 | included.vasopressin | 2 |
| 28 | interaction-and | 1 |
| 29 | male.the | 1 |
| 30 | neurotoxicities-were | 1 |
| 31 | noticed.the | 1 |
| 32 | prechewed | 1 |
| 33 | precommercial | 1 |
| 34 | preinformed | 1 |
| 35 | purpose-trained | 1 |
| 36 | quality-graded | 1 |
| 37 | ranked | 581 |
| 38 | rated | 3,724 |
| 39 | re-consulted | 1 |
| 40 | re-cultivate | 1 |
| 41 | regraded | 4 |
| 42 | retune | 1 |
| 43 | sanitised | 2 |
| 44 | scored | 2,442 |
| 45 | self-assessing | 1 |
| 46 | strokesand | 1 |
| 47 | trait-positive | 1 |
| 48 | valued | 369 |
| 49 | waiting.for | 1 |
| 50 | ytw | 2 |
| 1 | assessed. | 1 |
| 2 | 2.04/100 | 1 |
| 3 | 4.5/100 | 1 |
| 4 | 1.25/100 | 1 |
| 5 | 5.88/100 | 1 |
| 6 | 15,664 | 1 |
| 7 | quality-graded | 1 |
| 8 | regraded | 4 |
| 9 | began/wrote/astonished | 1 |
| 10 | ranked | 581 |
| 11 | preinformed | 1 |
| 12 | purpose-trained | 1 |
| 13 | dark-triggered | 2 |
| 14 | scored | 2,442 |
| 15 | anorexia/decreased | 1 |
| 16 | sanitised | 2 |
| 17 | canvassed | 5 |
| 18 | rated | 3,724 |
| 19 | re-consulted | 1 |
| 20 | valued | 369 |
| 21 | prechewed | 1 |
| 22 | aggrandized | 1 |
| 23 | interaction-and | 1 |
| 24 | strokesand | 1 |
| 25 | noticed.the | 1 |
| 26 | male.the | 1 |
| 27 | dissemination/cochrane | 1 |
| 28 | retune | 1 |
| 29 | gal-3-were | 1 |
| 30 | neurotoxicities-were | 1 |
| 31 | assesse | 1 |
| 32 | re-cultivate | 1 |
| 33 | fat-positive/inflammation-positive | 1 |
| 34 | trait-positive | 1 |
| 35 | future-proof | 1 |
| 36 | self-assessing | 1 |
| 37 | 'affecting | 1 |
| 38 | hoch | 2 |
| 39 | precommercial | 1 |
| 40 | as/than | 1 |
| 41 | included.vasopressin | 2 |
| 42 | excluded.for | 1 |
| 43 | estimated.for | 1 |
| 44 | waiting.for | 1 |
| 45 | impregnates | 1 |
| 46 | diabetes-is | 1 |
| 47 | harass | 1 |
| 48 | ytw | 2 |
| 49 | estrogens-specifically | 1 |
| 50 | archery | 2 |